![Christopher Kiritsy](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Christopher Kiritsy
Founder at
Precision Kapital LLC
Net worth: 38 205 $ as of 2026-06-29
Profile
Christopher P.
Kiritsy is the founder of Arisaph Pharmaceuticals, Inc., founded in 1999, where the titles held included President, Chief Executive Officer & Director from 2005 to 2018.
Mr. Kiritsy is the founder of Precision Kapital LLC, founded in 2018, holding the title of Member since 2018.
Mr. Kiritsy currently serves as an Independent Director at Palvella Therapeutics, Inc. starting in 2024.
Former positions include Chairman at Avaxia Biologics, Inc., Associate Director-Product Development at the University of Oregon, Director at Melinta Subsidiary Corp., Director at HTG Molecular Diagnostics, Inc., Independent Director at Pieris Pharmaceuticals, Inc. from 2016 to 2024, and CFO & Executive VP-Corporate Development at KOS Pharmaceuticals, Inc. Education includes an MBA from Boston University and an undergraduate degree from Bowdoin College.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
0% | 2026-06-09 | 250 ( 0% ) | 38 205 $ | 2026-06-29 |
Christopher Kiritsy active positions
| Companies | Position | Start |
|---|---|---|
Precision Kapital LLC | Founder | 2017-12-31 |
Former positions of Christopher Kiritsy
| Companies | Position | End |
|---|---|---|
| PIERIS PHARMACEUTICALS | Director/Board Member | 2024-12-12 |
Arisaph Pharmaceuticals, Inc.
 Arisaph Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Provides drug discovery services | Founder | 2017-12-31 |
KOS Pharmaceuticals, Inc.
 KOS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Director of Finance/CFO | 2005-05-22 |
| HTG MOLECULAR DIAGNOSTICS, INC. | Director/Board Member | - |
Melinta Subsidiary Corp.
 Melinta Subsidiary Corp. Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceutical products for the treatment of life-threatening infections | Director/Board Member | - |
Training of Christopher Kiritsy
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
55
1st degree connections
10
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 10 |
|---|---|
KOS Pharmaceuticals, Inc.
KOS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
HTG Molecular Diagnostics, Inc.
 HTG Molecular Diagnostics, Inc. Miscellaneous Commercial ServicesCommercial Services Provides molecular technology solutions | Commercial Services |
Arisaph Pharmaceuticals, Inc.
Arisaph Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Provides drug discovery services | Health Technology |
Avaxia Biologics, Inc.
 Avaxia Biologics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company | Health Technology |
Boston University
 Boston University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bowdoin College
 Bowdoin College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Oregon
 University of Oregon Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Melinta Subsidiary Corp.
Melinta Subsidiary Corp. Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceutical products for the treatment of life-threatening infections | Health Technology |
Pieris Pharmaceuticals, Inc.
 Pieris Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops and markets an anticalin-brand protein technology | Health Technology |
Precision Kapital LLC |
- Stock Market
- Insiders
- Christopher Kiritsy
